pharma news

News

UK moves ahead with GP patient data sharing plan

The UK government has asked the NHS to start putting together the platforms to allow anonymised primary care patient data to be used by researchers.

News

Man yawning, covering his mouth with his hand

FDA kicks off review of Takeda's narcolepsy hopeful

The FDA has started a priority review of Takeda's oveporexton for sleep disorder narcolepsy, setting up a decision in the third quarter of the year.

News

Kailera, Hengrui stake claim to oral weight loss category

Chasing Novo Nordisk and Eli Lilly, Kailera and Hengrui have reported 12.1% weight loss in phase 2 with their oral GIP/GLP-1 agonist ribupatide.

News

AstraZeneca raises guidance on stellar cancer drugs growth

AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron.

News

Takeda signs $1.7bn AI alliance with Iambic

Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.

News

Curran Simpson, Regenxbio's president and CEO

Dismay as FDA blocks Regenxbio's Hunter syndrome therapy

The FDA said it needs more information before it can approve Regenxbio's gene therapy for Hunter syndrome, in a devastating decision for patients.

UK moves ahead with GP patient data sharing plan

FDA kicks off review of Takeda's narcolepsy hopeful

Kailera, Hengrui stake claim to oral weight loss category

AstraZeneca raises guidance on stellar cancer drugs growth

Takeda signs $1.7bn AI alliance with Iambic

Dismay as FDA blocks Regenxbio's Hunter syndrome therapy

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks